Drug intelligence / Profile preview

shugan hewei

Development stage
Unknown
Lead developer
Liaoning University of Traditional Chinese Medicine
Administration
Oral
01

Overview

ShuGanHeWei (shugan hewei) is a traditional Chinese medicine (TCM) herbal formulation designed to "soothe the liver and harmonize the stomach." It is widely used in China for gastrointestinal disorders such as chronic atrophic gastritis and gastroesophageal reflux disease (GERD), especially when associated with symptoms like poor appetite, abdominal pain or fullness, nausea, vomiting, acid regurgitation, and abnormal bowel movements. The formula contains multiple herbal ingredients including Bupleurum falcatum root (chai hu), Atractylodes macrocephala root (bai zhu), Paeonia lactiflora root (bai shao), Citrus medica fruit (fo shou), Citrus reticulata peel (chen pi), Curcuma longa stem (yu jin), Saussurea costus root (mu xiang), Cyperus rotundus rhizome (xiang fu), Glycyrrhiza uralensis root/rhizome (gan cao), Lindera strychnifolia root (wu yao), Pogostemon cablin herb (huo xiang), Raphanus sativus fruit/lai fu zi and others[4][5]. Mechanistically, network pharmacology studies suggest that its main active compounds include quercetin, kaempferol and luteolin. These act on targets involved in inflammation and immunity such as TGF-β1, IL-1β/IL-4/IL-10/IL-2/CXCL8/CXCL10/MAPK1/MAPK3/FOS. For mental health comorbidities like anxiety/depression with GERD it may modulate GABA-A receptor subunits GABRA1/GABRA2/GABRA3/GABRA5/GABRA6[3]. Clinical studies show efficacy for refractory GERD—especially when combined with rabeprazole—and chronic atrophic gastritis; it improves both GI symptoms and quality of life measures[1][2].

Brand names
Shugan Hewei WanTRT Shugan Hewei Wan
Other names
ShuGanHeWei formulaShuGanHeWei recipeShuGanHeWei therapy
02

Targets

TGFB1 (Transforming growth factor Beta-1 proprotein)IL8 (C-X-C Motif Chemokine Ligand 8)GABRR (GABA-A receptor subunit rho)IL10 (Interleukin-10)FOS (Activator Protein 1)IL-4 (Interleukin 4)IL1B (Interleukin-1 beta)IL-2 (Interleukin 2)CXCL10 (C-X-C Motif Chemokine Ligand 10)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on shugan hewei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shugan hewei.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call